Gamida Cell Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of GMDA.Q?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders4,079,2202.65%
Public Companies4,336,7592.82%
Institutions35,727,12523.2%
General Public109,907,84971.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 45.9%.


Top Shareholders

Top 25 shareholders own 27.29% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.22%
FMR LLC
8,047,054US$136.8k0.06%no data
3.36%
Community US Fund Management, Inc.
5,169,471US$87.9k0%no data
2.82%
Novartis AG
4,336,759US$73.7k0%no data
2.74%
Highbridge Capital Management, LLC
4,222,973US$71.8k0%no data
2.43%
Levin Capital Strategies, L.P.
3,747,630US$63.7k0%0.01%
2.1%
Meitav Investment House Ltd
3,237,537US$55.0k-11.4%no data
1.95%
Stonepine Capital Management LLC
3,000,000US$51.0k0%0.04%
1.68%
Clal Biotechnology Industries Ltd.
2,581,746US$43.9k0%0.46%
0.89%
Julian Adams
1,378,127US$23.4k988%no data
0.52%
Nantahala Capital Management, LLC
800,000US$13.6k0%no data
0.52%
Sterne Agee Asset Management, Inc.
793,958US$13.5k0%no data
0.46%
Michele Korfin
706,380US$12.0k663%no data
0.38%
Abigail Jenkins
581,527US$9.9k328%no data
0.38%
Caspar Towarzystwo Funduszy Inwestycyjnych S.A.
579,000US$9.8k0%0.04%
0.33%
Ronit Simantov
512,636US$8.7k564%no data
0.22%
Pacific Life Fund Advisors LLC
334,500US$5.7k0%no data
0.19%
Qube Research & Technologies Ltd
297,812US$5.1k-11.9%no data
0.19%
BlackRock, Inc.
287,565US$4.9k-0.59%no data
0.18%
Joshua Patterson
282,096US$4.8k340%no data
0.15%
Leavell Investment Management, Inc.
235,000US$4.0k0%no data
0.13%
UBS Asset Management AG
201,000US$3.4k0%no data
0.13%
Group One Trading LP, Asset Management Arm
193,472US$3.3k-14.1%no data
0.12%
Stephen Wills
190,077US$3.2k1,530%no data
0.11%
Shawn Tomasello
164,577US$2.8k1,310%no data
0.1%
Kenneth Moch
155,900US$2.7k7,700%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/05/26 03:15
End of Day Share Price 2024/05/24 00:00
Earnings2024/03/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Gamida Cell Ltd. is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew CrossAlliance Global Partners
Matthew LuchiniBMO Capital Markets Equity Research
Vernon BernardinoH.C. Wainwright & Co.